Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity. InaJEMD - Indonesian Journal of Endocrinology Metabolism and Diabetes, [S. l.], v. 1, n. 2, p. 96–110, 2024. Disponível em: https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol1-no2-section12. Acesso em: 3 aug. 2025.